Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $2.7 million.

  • Bio's Gains from Investment Securities rose 2473.67% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 2473.67%. This contributed to the annual value of $2.1 million for FY2024, which is 200.1% down from last year.
  • According to the latest figures from Q3 2025, Bio's Gains from Investment Securities is $2.7 million, which was up 2473.67% from $2.8 million recorded in Q2 2025.
  • Bio's 5-year Gains from Investment Securities high stood at $2.8 million for Q2 2025, and its period low was $1000.0 during Q3 2022.
  • For the 5-year period, Bio's Gains from Investment Securities averaged around $1.7 million, with its median value being $1.9 million (2021).
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first crashed by 9994.15% in 2022, then skyrocketed by 22012640.0% in 2023.
  • Over the past 5 years, Bio's Gains from Investment Securities (Quarter) stood at $1.7 million in 2021, then tumbled by 99.94% to $1000.0 in 2022, then soared by 60900.0% to $610000.0 in 2023, then plummeted by 98.2% to $11000.0 in 2024, then skyrocketed by 24040.65% to $2.7 million in 2025.
  • Its last three reported values are $2.7 million in Q3 2025, $2.8 million for Q2 2025, and $2.5 million during Q1 2025.